Is VYNE Therapeutics Inc. (VYNE) a Buy, Sell, or Hold?
NASDAQ : VYNE
VYNE Therapeutics Inc.
$0.761 USD
-$0.01 (-0.85%)
- Volume
- 984.55K
- Average Volume
- 534.06K
- Market Capitalization
- $12.68M
- P/E Ratio
- -1.57
- Dividend Yield
- 0.00%
- Price Target
- $5.75
- Year High
- $1.60
- Year Low
- $0.28
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $20.86
Insider Activity Summary (Last 12 Months)
Insiders Buying
5
Insiders Selling
16
Amount of Insider Selling
$95333
VYNE Insider Buying/Selling by Quarter
VYNE Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2026-06-30 | F-InKind | 0.6507 | 2026-07-02 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2026-06-30 | F-InKind | 0.6507 | 2026-07-02 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2026-06-30 | F-InKind | 0.6507 | 2026-07-02 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2026-06-30 | F-InKind | 0.6507 | 2026-07-02 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2026-05-29 | A-Award | 0.31 | 2026-06-02 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2026-03-31 | F-InKind | 0.5975 | 2026-04-02 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2026-03-31 | F-InKind | 0.5975 | 2026-04-02 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2026-03-31 | F-InKind | 0.5975 | 2026-04-02 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2026-03-31 | F-InKind | 0.5975 | 2026-04-02 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2025-12-31 | F-InKind | 0.5801 | 2026-01-05 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2025-12-31 | F-InKind | 0.5801 | 2026-01-05 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2025-12-31 | F-InKind | 0.5801 | 2026-01-05 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2025-12-31 | F-InKind | 0.5801 | 2026-01-05 |
| Little Elisabeth Sandoval | director | 2025-12-12 | A-Award | 0.3756 | 2025-12-15 |
| LEPORE PATRICK G | director | 2025-12-12 | A-Award | 0.3756 | 2025-12-15 |
| Basta Steven L | director | 2025-12-12 | A-Award | 0.3756 | 2025-12-15 |
| BARBARI SHARON | director | 2025-12-12 | A-Award | 0.3756 | 2025-12-15 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2025-09-30 | F-InKind | 0.335 | 2025-10-02 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2025-09-30 | F-InKind | 0.335 | 2025-10-02 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2025-09-30 | F-InKind | 0.335 | 2025-10-02 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2025-09-30 | F-InKind | 0.335 | 2025-10-02 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2025-06-30 | F-InKind | 1.65 | 2025-07-02 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2025-06-30 | F-InKind | 1.65 | 2025-07-02 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2025-06-30 | F-InKind | 1.65 | 2025-07-02 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2025-06-30 | F-InKind | 1.65 | 2025-07-02 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2025-06-02 | A-Award | 0.81 | 2025-06-03 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2025-06-02 | A-Award | 0.81 | 2025-06-03 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2025-03-31 | F-InKind | 1.58 | 2025-04-02 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2025-03-31 | F-InKind | 1.58 | 2025-04-02 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2025-03-31 | F-InKind | 1.58 | 2025-04-02 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2025-03-31 | F-InKind | 1.58 | 2025-04-02 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2025-01-21 | A-Award | 2.77 | 2025-01-23 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2025-01-21 | A-Award | 2.77 | 2025-01-23 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2025-01-21 | A-Award | 2.77 | 2025-01-23 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2025-01-21 | A-Award | 2.77 | 2025-01-23 |
| LEPORE PATRICK G | director | 2025-01-15 | P-Purchase | 2.92 | 2025-01-16 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2024-12-31 | F-InKind | 3.35 | 2025-01-02 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2024-12-31 | F-InKind | 3.35 | 2025-01-02 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2024-12-31 | F-InKind | 3.35 | 2025-01-02 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2024-12-31 | F-InKind | 3.35 | 2025-01-02 |
| Borowski Christine | director | 2024-12-12 | A-Award | 2.4 | 2024-12-13 |
| LEPORE PATRICK G | director | 2024-12-12 | A-Award | 2.4 | 2024-12-13 |
| Basta Steven L | director | 2024-12-12 | A-Award | 2.4 | 2024-12-13 |
| BARBARI SHARON | director | 2024-12-12 | A-Award | 2.4 | 2024-12-13 |
| Sandoval Elisabeth | director | 2024-12-12 | A-Award | 2.4 | 2024-12-13 |
| Bruno Anthony D | director | 2024-12-12 | A-Award | 2.4 | 2024-12-13 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2024-11-30 | A-Award | 2.1 | 2024-12-03 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2024-09-30 | F-InKind | 1.88 | 2024-10-02 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2024-09-30 | F-InKind | 1.88 | 2024-10-02 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2024-09-30 | F-InKind | 1.88 | 2024-10-02 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2024-09-30 | F-InKind | 1.88 | 2024-10-02 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2024-07-01 | F-InKind | 1.92 | 2024-07-03 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2024-07-01 | F-InKind | 1.92 | 2024-07-03 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2024-07-01 | F-InKind | 1.92 | 2024-07-03 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2024-07-01 | F-InKind | 1.92 | 2024-07-03 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2024-05-31 | A-Award | 2.159 | 2024-06-04 |
| Zeronda Tyler | officer: CHIEF FINANCIAL OFFICER | 2024-04-01 | F-InKind | 3.08 | 2024-04-03 |
| Stuart Iain | officer: CHIEF SCIENTIFIC OFFICER | 2024-04-01 | F-InKind | 3.08 | 2024-04-03 |
| Harsch Mutya | officer: CHIEF LEGAL OFFICER AND GC | 2024-04-01 | F-InKind | 3.08 | 2024-04-03 |
| Domzalski David | director, officer: PRESIDENT AND CEO | 2024-04-01 | F-InKind | 3.08 | 2024-04-03 |
| Zeronda Tyler | officer: Chief Financial Officer | 2024-01-01 | A-Award | 0 | 2024-01-03 |
| Zeronda Tyler | officer: Chief Financial Officer | 2024-01-02 | F-InKind | 2.28 | 2024-01-03 |
| Zeronda Tyler | officer: Chief Financial Officer | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| Stuart Iain | officer: Chief Scientific Officer | 2024-01-01 | A-Award | 0 | 2024-01-03 |
| Stuart Iain | officer: Chief Scientific Officer | 2024-01-02 | F-InKind | 2.28 | 2024-01-03 |
| Stuart Iain | officer: Chief Scientific Officer | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| Harsch Mutya | officer: Chief Legal Officer and GC | 2024-01-01 | A-Award | 0 | 2024-01-03 |
| Harsch Mutya | officer: Chief Legal Officer and GC | 2024-01-02 | F-InKind | 2.28 | 2024-01-03 |
| Harsch Mutya | officer: Chief Legal Officer and GC | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| Domzalski David | director, officer: President and CEO | 2024-01-01 | A-Award | 0 | 2024-01-03 |
| Domzalski David | director, officer: President and CEO | 2024-01-02 | F-InKind | 2.28 | 2024-01-03 |
| Domzalski David | director, officer: President and CEO | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| Sandoval Elisabeth | director | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| LEPORE PATRICK G | director | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| Bruno Anthony D | director | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| Basta Steven L | director | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| BARBARI SHARON | director | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| Borowski Christine | director | 2024-01-01 | A-Award | 2.33 | 2024-01-03 |
| Borowski Christine | director: | 2023-12-29 | 0 | 2024-01-03 | |
| Zeronda Tyler | officer: Chief Financial Officer | 2023-12-13 | A-Award | 0 | 2023-12-15 |
| Zeronda Tyler | officer: Chief Financial Officer | 2023-12-13 | A-Award | 2.7 | 2023-12-15 |
| Stuart Iain | officer: Chief Scientific Officer | 2023-12-13 | A-Award | 0 | 2023-12-15 |
| Stuart Iain | officer: Chief Scientific Officer | 2023-12-13 | A-Award | 2.7 | 2023-12-15 |
| Harsch Mutya | officer: Chief Legal Officer and GC | 2023-12-13 | A-Award | 0 | 2023-12-15 |
| Harsch Mutya | officer: Chief Legal Officer and GC | 2023-12-13 | A-Award | 2.7 | 2023-12-15 |
| Domzalski David | director, officer: President and CEO | 2023-12-13 | A-Award | 0 | 2023-12-15 |
| Domzalski David | director, officer: President and CEO | 2023-12-13 | A-Award | 2.7 | 2023-12-15 |
| Sandoval Elisabeth | director | 2023-12-13 | A-Award | 2.7 | 2023-12-15 |
| LEPORE PATRICK G | director | 2023-12-13 | A-Award | 2.7 | 2023-12-15 |
| Bruno Anthony D | director | 2023-12-13 | A-Award | 2.7 | 2023-12-15 |
| Basta Steven L | director | 2023-12-13 | A-Award | 2.7 | 2023-12-15 |
| BARBARI SHARON | director | 2023-12-13 | A-Award | 2.7 | 2023-12-15 |
| Domzalski David | director, officer: President and CEO | 2023-11-30 | A-Award | 2.8135 | 2023-12-04 |
| LEPORE PATRICK G | director | 2023-11-15 | P-Purchase | 3.906 | 2023-11-17 |
| AI Biotechnology LLC | 10 percent owner | 2023-11-01 | 0 | 2023-11-13 | |
| AI Biotechnology LLC | 10 percent owner | 2023-11-01 | 0.0001 | 2023-11-13 | |
| Zeronda Tyler | officer: Chief Financial Officer | 2023-10-02 | F-InKind | 3.83 | 2023-10-04 |
| Stuart Iain | officer: Chief Scientific Officer | 2023-10-02 | F-InKind | 3.83 | 2023-10-04 |
| Harsch Mutya | officer: Chief Legal Officer and GC | 2023-10-02 | F-InKind | 3.83 | 2023-10-04 |
| Domzalski David | director, officer: President and CEO | 2023-10-02 | F-InKind | 3.83 | 2023-10-04 |